IctioBiotic is a Chilean biotechnology company committed to developing novel oral biotherapeutics that are friendly with the environment and allow sustainable development of the aquaculture industry.
Our mission is to become a key supplier of oral biotherapeutics that help reduce diseases and improve the sanitary status of fish farms.
With our products we aim at helping people consume healthy and sustainable protein from aquaculture, free of antibiotics and other chemicals. To achieve this, we have developed new class of oral biotherapeutics based on our proprietary platform of modified food grade microbes that produce variety proteins to be used as immunostimulants and vaccines with potential for other species and other industries.
Limitations in the norwegian snow crab catch Norway
The total Norwegian quota for catching snow crab is 6725 tonnes for 2022.
The Ministry of Trade and Industry has asked the directorate to provide a comprehensive assessment of future catches of snow ...
Import value of frozen pollack increased by 253% South Korea
The total number of frozen pollack imported in April 2022 was 32.3% (140,670 tons out of the 435,571 tons total korean seafood imports), higher than the ratio of 14.68% (51,814 tons out of 352,994...
Loophole leaves migrant crews open to systematic abuse United Kingdom
A report by the International Transport Workers’ Federation (ITF) claims that migrant fishermen working on UK vessels are vulnerable to systematic labour exploitation as the Government refuses c...
Copyright 1995 - 2022 Seafood Media Group Ltd.| All Rights Reserved. DISCLAIMER
IctioBiotic SpA.
Shareholder companies:
Print
